Q: Pat: BioLineRx is an Israeli company working in several health areas. What’s your take on the company, Pat? Thanks.

A: BioLineRx (ADR), $1.12, symbol BLRX on Nasdaq (ADRs outstanding: 104.1 million; Market cap: $118.0 million; www.biolinerx.com), is a clinical-stage biopharmaceutical company that aims to identify, license and develop promising therapeutic medications and treatments. It’s based in Israel.

The company licenses the new drug compounds developed… Read More